The NMDA receptor antagonist MK-801 differentially modulates μ and κ opioid actions in spinal cord in vitro

Pain

Volumn 66, Issue 2-3, 1996, Pages 343-349

  Feng, Jianqiang ^a   Kendig, Joan J ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dependence; Hyperalgesia; NMDA receptor; Opiate; Opioid; Spinal cord; Tolerance

Indexed keywords

DIZOCILPINE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NALOXONE; NORBINALTORPHIMINE; OPIATE; OPIATE AGONIST;

ANALGESIC ACTIVITY; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG TOLERANCE; ETIOLOGY; HYPERALGESIA; NEUROTRANSMISSION; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD;

EID: 0030220140     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3959(96)03024-2     Document Type: Article

References (47)

1. Atweh S.A., Kuhar M.J. Autoradiographic localisation of opiate receptors in rat brain. I. Spinal cord and lower medulla. Brain Res. 124:1977;53-67.
2. Basbaum A.I. Insights into the development of opioid tolerance. Pain. 61:1995;349-352.
3. Bederson J.B., Fields H.L., Barbaro N.M. Hyperalgesia during naloxone-precipitated withdrawal from morphine is associated with increased on-cell activity in the rostral ventromedial medulla. Somatosens. Mot. Res. 7:1990;185-203.
4. Bhargava H.N., Matwyshyn G.A. Dizocilpine (MK-801) blocks tolerance to the analgesic but not to the hyperthermic effect of morphine in the rat. Pharmacology. 47:1993;344-350.
5. Bhargava H.N., Thorat S.N. Effect of dizocilpine (MK-801) on analgesia and tolerance induced by U-50,488H, a κ-opioid receptor agonist, in the mouse. Brain Res. 649:1994;111-116.
6. Bhargava H.N., Ramarao P., Gulati A. Effects of morphine in rats treated chronically with U-50,488H, a κ-opioid receptor agonist. Eur. J. Pharmacol. 162:1989;257-264.
7. Blasig J., Herz A., Reinhold K., Zieglgansberger S. Development of physical dependence on morphine in respect to time and dosage and quantification of precipitated withdrawal syndrome in rats. Psychopharmacology. 331:1973;19-38.
8. Brockmeyer D., Kendig J.J. Selective effects of ketamine on amino acid-mediated pathways in neonatal rat spinal cord. Br. J. Anaesth. 74:1995;79-84.
9. Chapman V., Dickenson A.H. The combination of NMDA antagonism and morphine produces profound antinociception in the rat dorsal horn. Brain Res. 573:1992;321-323.
10. Chen L., Huang L.M. Sustained potentiation of NMDA receptor-mediated glutamate responses through activation of protein kinase C by a μ opioid. Neuron. 7:1991;319-326.
11. Dashwood M.R., Fleetwood-Walker S.M., Gilbey M.P., Mitchell R., Spyer K.M. Distribution of α-adrenergic, muscarinic and opiate receptors within lumbar spinal cord of cat. J. Physiol. (Lond.). 362:1985;42P.
12. Dickenson A.H. A cure for wind up: NMDA receptor antagonists as potential analgesics. Trends Pharmacol. Sci. 11:1990;307-309.
13. Elliott K., Minami N., Kolesnikov Y.A., Pasternak G.W., Inturrisi C.E. The NMDA receptor antagonists, LY274614 and MK-801, and the nitric oxide synthase inhibitor, NG-nitro- L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioids. Pain. 56:1994;69-75.
14. Feng J., Kendig J.J. Selective effects of alfentanil on nociceptive-related neurotransmission in neonatal rat spinal cord. Br. J. Anaesth. 74:1995;691-696.
15. Feng J., Kendig J.J. N-Methyl- D-aspartate receptors are implicated in hyperresponsiveness following naloxone reversal of alfentanil in isolated rat spinal cord. Neurosci. Lett. 189:1995;128-130.
16. Fields H.L., Emson P.C., Leigh B.K., Gilbert R.F.T., Iversen L.L. Multiple opiate receptor sites on primary afferent fibres. Nature (Lond.). 284:1980;351-353.
17. Gillan M.G.C., Jin W., Kosterlitz H.W., Paterson S.J. A highly selective ligand for the kappa binding site (U-50,488H). Br. J. Pharmacol. 79:1983;275P.
18. Gouarderes C., Cros J., Quirion R. Autoradiographic localisation of μ, δ, and κ opioid receptor binding sites in rat and guinea pig spinal cord. Neuropeptides. 6:1985;331-342.
19. Gutstein H.B., Trujillo K.A., Akil H. Does chronic nociceptive stimulation alter the development of morphine tolerance. Brain Res. 680:1995;173-179.
20. Horwell D.C. Kappa opioid analgesics. Drugs Future. 13:1988;1061-1071.
21. Kendig J.J., Savola M.K.T., Woodley S.J., Maze M. Alpha-2 adrenoceptors inhibit a nociceptive response in neonatal rat spinal cord. Eur. J. Pharmacol. 192:1991;293-300.
22. Kest M., Marek P., Liebeskind J.C. The specific N-methyl- D-aspartate (NMDA) receptor antagonist MK-801 blocks U-50,488H, but not morphine antinociception. Brain Res. 589:1992;139-142.
23. Lozier A.P., Kendig J.J. Long-term potentiation in an isolated peripheral nerve-spinal cord preparation. J. Neurophysiol. 74:1995;1001-1009.
24. Lutfy K., Hurlbut D.E., Weber E. Blockade of morphine-induced analgesia and tolerance in mice by MK-801. Brain Res. 616:1993;83-88.
25. Mack K.J., Killian A., Weyhenmeyer J.A. Comparison of mu, delta, and kappa opiate binding sites in rat brain and spinal cord. Life Sci. 34:1984;281-285.
26. Mao J., Price D.D., Mayer D.J. Thermal hyperalgesia in association with the development of morphine tolerance in rats: roles of excitatory amino acid receptors and protein kinase C. J. Neurosci. 14(4):1994;2301-2312.
27. Mao J., Price D.D., Mayer D.J. Experimental mononeuropathy reduces the antinociceptive effects of morphine: implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain. Pain. 61:1995;353-364.
28. Mao J., Price D.D., Mayer D.J. Increases in protein kinase C gamma immunoreactivity in the spinal cord of rats associated with tolerance to the analgesic effects of morphine. Brain Res. 677(2):1995;257-267.
29. Marek P., Ben-Eliyahu S., Gold M., Liebeskind J.C. Excitatory amino acid antagonists (kynurenic acid and MK-801) attenuate the development of morphine tolerance in the rat. Brain Res. 547:1991;77-81.
30. Mayer D.J., Mao J., Price D.D. The development of morphine tolerance and dependence is associated with translocation of protein kinase C. Pain. 61:1995;365-374.
31. Millan M.J. k-Opioid receptors and analgesia. Trends Pharmacol. Sci. 11:1990;70-76.
32. Nussbaumer J.-C., Yanagisawa M., Otsuka M. Pharmacologic properties of a C-fibre response evoked by saphenous nerve stimulation in an isolated spinal cord-nerve preparation of the newborn rat. Br. J. Pharmacol. 98:1989;373-382.
33. Otsuka M., Yanagisawa M. Effect of a tachykinin antagonist on a nociceptive reflex in the isolated spinal cord-tail preparation of the newborn rat. J. Physiol. 395:1988;255-270.
34. Saucier D.M., Kavaliers M. Antagonistic effects of the selective, competitive N-methyl- D-aspartate (NMDA) receptor antagonist, NPC 12626, on kappa opiate-induced analgesia in male deer mice. Brain Res. 637:1994;292-296.
35. 2-adrenoceptor agonist suppress nociceptive neurotransmission in neonatal rat spinal cord. Anesthesiology. 75:1991;489-498.
36. Schmauss C., Yaksh T.L. In vivo studies on spinal opiate receptor systems mediating antinociception. II. Pharmacological profiles suggesting a differential association of mu, delta, and kappa receptors with visceral, chemical and cutaneous thermal stimuli in the rat. J. Pharmacol. Exp. Ther. 228:1984;1-12.
37. Takemori A.E., Portoghese P.S. Evidence for the interaction of morphine with kappa and delta opioid receptors to induce analgesia in β-funaltrexamin treated mice. J. Pharmacol. Exp. Ther. 243:1987;91-94.
38. Tanganelli S., Antonelli T., Morari M., Bianchi C., Beani L. Glutamate antagonists prevent morphine withdrawal in mice and guinea pigs. Neurosci. Lett. 122:1991;270-272.
39. Tiseo P.J., Inturrisi C.E. Attenuation and reversal of morphine tolerance by the competitive N-methyl- D-aspartate receptor antagonist, LY274614. J. Pharmacol. Exp. Ther. 264:1993;1090-1096.
40. Trujillo K.A., Akil H. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science. 251:1991;85-87.
41. Von Voigtlander P.F., Lahti R.A., Ludens J.H. U-50,488H, selective and structurally novel non-mu (kappa) opioid agonist. J. Pharmacol. Exp. Ther. 224:1983;7-12.
42. Wang J.K., Nauss L.A., Thomas J.E. Pain relief by intrathecally applied morphine in humans. Anesthesiology. 50:1979;149-151.
43. Woodley S.J., Kendig J.J. Substance P and NMDA receptors mediate a slow nociceptive ventral root potential in neonatal rat spinal cord. Brain Res. 559:1991;17-21.
44. Yaksh T.L. In vivo studies on spinal opiate receptor systems mediating antinociception. I. Mu and delta receptor profiles in the primate. J. Pharmacol. Exp. Ther. 226:1983;303-316.
45. Yaksh T.L., Reddy S.V.R. Studies on the analgesic effects associated with intrathecal action of opiates, α-adrenergic agonists and baclofen. Anesthesiology. 54:1981;451-467.
46. Yanagisawa M., Murakoshi T., Tamai S., Otsuka M. Tail-pinch method in vitro and the effects of some antinociceptive compounds. Eur. J. Pharmacol. 106:1985;231-239.
47. 3H-phorbol 12,13-dibutyrate binding in spinal cord dorsal horn as well as persistent pain and hyperalgesia, which is reduced by inhibition of protein kinase C. J. Neurosci. 15(5):1995;3263-3272.